Synthesis and anti-PRV virus activity of novel N-pyridinium bipyrazole dimer derivatives

doi:10.23/cjoc202309017

Chinese Journal of Organic Chemistry Previous Articles Next Articles

新型含N-吡啶联吡唑类二聚体衍生物的合成及抗猪伪狂犬病毒(PRV)活性评价

侯学会^a, 姚晨^c, 宋锦清^b, 杨菲菲^b, 何张旭^b, 陈晓培^a, 张京玉^b,*

^a河南牧业经济学院理学部郑州 450046;
^b河南中医药大学药学院郑州 450046;
^c河南农业大学动物医学院郑州 450046

收稿日期:2023-09-18 修回日期:2023-12-15
基金资助:
河南省自然科学基金项目(No. 202300410264)、河南省科技攻关项目(No. 232102111051)和中国博士后科学基金(2022M721060)资助项目

Synthesis and anti-PRV virus activity of novel N-pyridinium bipyrazole dimer derivatives

Hou Xuehui^a, Yao Chen^c, Song Jinqing^b, Yang Feifei^b, He Zhangxu^b, Chen Xiaopei^a, Zhang Jingyu^b,*

^aFaculty of Science, Henan University of Animal Husbandry and Economy, Zhengzhou 450046;
^bHenan University of Traditional Chinese Medicine, School of Pharmacy, Zhengzhou, 450046;
^cFaculty of Science, Henan University of Animal Husbandry and Economy, Zhengzhou 450046

Received:2023-09-18 Revised:2023-12-15
Contact: * E-mail: jyzhang2004@126.com
Supported by:
Natural Science Foundation of Henan Province (No. 202300410264) and the Key Scientific,Technological Project of He-nan Province (No. 232102111051) and China Postdoctoral Science Foundation (2022M721060).

1. .pdf(7403KB)

Abstract

The porcine pseudorabies virus (PRV) leading to severe neurological and respiratory damage can infects a wide range of vertebrates and humans, which raises concerns regarding the potential cross-species transmission of PRV. However, there is currently a lack of specific antiviral treatments available for PRV. In this study, we designed and synthesized 25 dimer derivatives containing N-pyridine bipyrazole moiety based on the principles of molecular splicing and electron isoarrangement. The structures of these compounds were characterized using ¹H NMR and ¹³C NMR analysis. Preliminary bioassay revealed that most of the compounds exhibited potent anti-PRV activity at a concentration of 10 μM while demonstrating no or minimal toxicity towards PK-15 cells. These novel N-pyridinium bipyrazole dimer derivatives could be regarded as anti-PRV agents for further optimization and development.

Key words: N-pyridinium bipyrazole, dimer derivatives, anti-PRV virus activity

Cite this article

Hou Xuehui, Yao Chen, Song Jinqing, Yang Feifei, He Zhangxu, Chen Xiaopei, Zhang Jingyu. Synthesis and anti-PRV virus activity of novel N-pyridinium bipyrazole dimer derivatives[J]. Chinese Journal of Organic Chemistry, doi: 10.23/cjoc202309017.

Export EndNote|Reference Manager|ProCite|BibTeX|RefWorks

share this article

References

[1] Ketusing N.; Reeves A.; Portacci K.; Yano T.; Olea-Popelka F.; Keefe T.; Salman M. Transbound. Emerg. Dis. 2014, 61, 169~176.
[2] Zhou M.; Abid M.; Cao S.; Zhu S.Viruses. 2022, 14, 1753.
[3] Li X.D.; Fu S.H.; Chen L.Y.; Li F.; Deng J.H.; Lu X.C.; Wang H.Y.; Tian K.G. Biomed. Environ. Sci. 2020, 33, 444~447.
[4] Liu Q.; Wang X.; Xie C.; Ding S.; Yang H.; Guo S.; Li J.; Qin L.; Ban F.; Wang D.; Wang C.; Feng L.; Ma H.; Wu B.; Zhang L.; Dong C.; Xing L.; Zhang J.; Chen H.; Yan R.; Wang X.; Li W. Clin. Infect. Dis. 2021, 73, e3690~e3700.
[5] Wang D.; Tao X.; Fei M.; Chen J.; Guo W.; Li P.; Wang J.[J]. Neurovirol. 2020, 26, 442~448.
[6] Pomeranz L.E.; Reynolds A. E.; Hengartner C. [J]. Microbiol. Mol. Biol. Rev. 2005, 69, 462~500.
[7] Yang L.; Wang M.; Cheng A.; Yang Q.; Wu Y.; Jia R.; Liu M.; Zhu D.; Chen S.; Zhang S.; Zhao X.; Huang J.; Wang Y.; Xu Z.; Chen Z.; Zhu L.; Luo Q.; Liu Y.; Yu Y.; Zhang L.; Tian B.; Pan L Rehman M.U.; Chen X. Front Immunol. 2019, 10, 2196.
[8] Xie J.; Li X.; Yang S Yan Z.; Chen L.; Yang Y.; Li D.; Zhang X.; Feng R. Front Microbiol. 2022, 13, 932842.
[9] Kong Z.; Yin H.; Wang F.; Liu Z.; Luan X.; Sun L.; Liu W.; Shang Y.PLoS Pathog. 2022, 18, e1010544.
[10] Lu X.; Wang X.; Cheng H.; Wang X.; Liu C.; Tan X. Ann Med. 2023, 55, 2210845.
[11] Xu L.; Liu M.; Chen H.; Zhang L.; Xu Q.; Zhan Z.; Xu Z.; Liu S.; Wu S.; Zhang X.; Qin Q.; Wei J. Fish Shellfish Immunol. 2023, 140, 108990.
[12] Du H.; Kou M.; Deng W.; Zhou X.; Zhang X.; Huang Z.; Ren B.; Cai X.; Xu S.; Chen Y.; Chen L.; Chen C.; Bao H.; Chen Q.; Li D. Biomed. Pharmacother. 2023, 165, 115188.
[13] Ramanjulu J.M.; Pesiridis G.S.; Yang J.; Concha N.; Singhaus R.; Zhang S.Y.; Tran J.L.; Moore P.; Lehmann S.; Eberl H.C.; Muelbaier M.; Schneck J.L.; Clemens J.; Adam M.; Mehlmann J.; Romano J.; Morales A.; Kang J.; Leister L.; Graybill T.L.; Charnley A.K.; Ye G.; Nevins N.; Behnia K.; Wolf A.I.; Kasparcova V.; Nurse K.; Wang L.; Puhl A.C.; Li Y.; Klein M.; Hopson C.B.; Guss J.; Bantscheff M.; Bergamini G.; Reilly M.A.; Lian Y.; Duffy K.J.; Adams J.; Foley K.P.; Gough P.J.; Marquis R.W.; Smothers J.; Hoos A.; Bertin [J]. Nature. 2018, 564, 439~443.
[14] Liu Y.; Lu X.; Qin N.; Qiao Y.; Xing S.; Liu W.; Feng F.; Liu Z.; Sun H. Eur. J. Med.Chem. 2021, 211, 113113.
[15] Berthelot J.M.; Lioté F.; Maugars Y.; Sibilia [J]. Front Immunol. 2020, 11, 607069.
[16] Hou S.; Lan X.J.; Li W.; Yan X.L.; Chang J.J.; Yang X.H.; Sun W.; Xiao J.H.; Li S. Bioorg Chem. 2020,95, 103556.
[17] Song X.; Peng Y.; Wang X.; Chen Q.; Lan X.; Shi F. Clin Transl Oncol. 2023, 25, 1545~1553.
[18] Chin E.N.; Yu C.; Vartabedian V.F.; Jia Y.; Kumar M.; Gamo A.M.; Vernier W.; Ali S.H.; Kissai M.; Lazar D.C.; Nguyen N.; Pereira L.E.; Benish B.; Woods A.K.; Joseph S.B.; Chu A.; Johnson K.A.; Sander P.N.; Martínez-Peña F.; Hampton E.N.; Young T.S.; Wolan D.W.; Chatterjee A.K.; Schultz P.G.; Petrassi H.M.; Teijaro J.R.; Lairson L.L. Science, 2020, 369. 993~999.
[19] Sali T.M.; Pryke K.M.; Abraham J.; Liu A.; Archer I.; Broeckel R.; Staverosky J.A.; Smith J.L.; Al-Shammari A.; Amsler L.; Sheridan K.; Nilsen A.; Streblow D.N.; DeFilippis V.R. PLoS Pathog. 2015, 11, e1005324.
[20] Luo M.; Groaz E.; Snoeck R.; Andrei G.; Herdewijn P.ACS Med Chem Lett. 2020, 11, 1410~1415.
[21] Suita K.; Fujita T.; Cai W.; Hidaka Y.; Jin H.; Prajapati R.; Umemura M.; Yokoyama U.; Sato M.; Knollmann B.C.; Okumura S.; Ishikawa Y. Pflugers Arch. 2018, 470, 923~935.
[22] Pertusati F.; Serafini S.; Albadry N.; Snoeck R.; Andrei G. Antiviral Res. 2017, 143, 262~268.
[23] Hew K.; Dahlroth S.L.; Veerappan S.; Pan L.X.; Cornvik T.; Nordlund P. PLoS One. 2015, 10, e0143947.
[24] Ramírez D.; Mejia-Gutierrez M.; Insuasty B.; Rinné S.; Kiper A.K.; Platzk M.; Müller T.; Decher N.; Quiroga J.; De-la-Torre P.; González W. Molecules. 2021, 26, 3897.
[25] Safdar M.H.; Hasan H.; Afzal S.; Hussain Z. Mini Rev Med Chem. 2018, 18, 1047~1063.
[26] Sribalan R.; Banuppriya G.; Kirubavathi M.; Jayachitra A.; Padmini V.Bioor Med Chem Lett. 2016, 26, 5624~5630.
[27] Bauer V.J.; Dalalian H.P.; Fanshawe W.J.; Safir S.R. [J] Med Chem. 1968, 11, 981~984.
[28] Madhu P.; Sivakumar P.[J] Photochem. 2019, 371, 341~348.
[29] Nithyabalaji R.; Krishnan H.; Sribalan R.[J] Mol Struct. 2019, 1186, 1~10.
[30] Wiatrak B.; Kubis-Kubiak A.; Piwowar A.; Barg E.Cells. 2020, 9, 958.
[31] Massai D.; Isu G.; Madeddu D.; Cerino G.; Falco A.; Frati C.; Gallo D.; Deriu M.A.; Falvo D'Urso Labate G.; Quaini F.; Audenino A.; Morbiducci U. PLoS One. 2016, 11, e0154610.
[32] Das R.; Roosloot R.; van Pel M.; Schepers K.; Driessen M.; Fibbe W.E.; de Bruijn J.D.; Roelofs H. [J] Transl Med. 2019,17, 241.
[33] Huang J.; Qi Y.; Wang A.; Huang C.; Liu X.; Yang X.; Li L.; Zhou R. Virol J. 2020, 17, 18.

新型含N-吡啶联吡唑类二聚体衍生物的合成及抗猪伪狂犬病毒(PRV)活性评价

Synthesis and anti-PRV virus activity of novel N-pyridinium bipyrazole dimer derivatives

PDF

Supporting Info.

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 0

Recommended Articles

Metrics

Comments